Satoshi Nishioka

Efficacy and safety of dosage-escalation of low-dosage esaxerenone added to a RAS inhibitor in hypertensive patients with type 2 diabetes and albuminuria: a single-arm, open-label study

Hiroshi Itoh, Sadayoshi Ito, Hiromi Rakugi et al. · Hypertension Research · 2019 · 53 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

The cyclin-dependent kinase inhibitor p21 is essential for the beneficial effects of renal ischemic preconditioning on renal ischemia/reperfusion injury in mice

Satoshi Nishioka, Daisuke Nakano, Kento Kitada et al. · Kidney International · 2013 · 50 citations · Full text

Medicine, Molecular Medicine, Nephrology +14

Calcitonin Gene-Related Peptide Regulates Type IV Hypersensitivity through Dendritic Cell Functions

Norihisa Mikami, Kaori Sueda, Ogitani Yusuke et al. · PLoS ONE · 2014 · 47 citations · Full text

Life Sciences, Immunology, Neurobiology +17

Screening for Aetiology of Thrombophilia: A High Prevalence of Protein S Abnormality

Hiroko Tsuda, Sachiko Hattori, Sohei Tanabe et al. · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · 1999 · 44 citations

Medicine, Genetics, Hematology +15

Latent <scp>I</scp>g<scp>A</scp> deposition from donor kidneys does not affect transplant prognosis, irrespective of mesangial expansion

Tadashi Sofue, Masashi Inui, Taiga Hara et al. · Clinical Transplantation · 2013 · 35 citations

Medicine, Nephrology, Surgery +11